Log in
TSE:NRI

Nuvo Pharmaceuticals Stock Forecast, Price & News

C$0.89
+0.04 (+4.71 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
C$0.89
Now: C$0.89
C$0.89
50-Day Range
C$0.68
MA: C$0.75
C$0.85
52-Week Range
C$0.28
Now: C$0.89
C$1.20
Volume1,115 shs
Average Volume20,081 shs
Market CapitalizationC$10.14 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nuvo Pharmaceuticals Inc., a commercial healthcare company, produces and sells pharmaceutical products in the United States, Canada, and Europe. It offers Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of osteoarthritis of the knee; Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch that provides local analgesia prior to painful needle procedures, such as dialysis, blood draws, and pediatric needles; and Resultz, an over-the-counter product intended to kill head lice and remove their eggs from hair. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-6736980

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$78.31 million
Cash FlowC$1.56 per share
Book ValueC$1.83 per share

Profitability

Miscellaneous

Employees97
Market CapC$10.14 million
Next Earnings Date10/29/2020 (Estimated)
OptionableNot Optionable
C$0.89
+0.04 (+4.71 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NRI News and Ratings via Email

Sign-up to receive the latest news and ratings for NRI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nuvo Pharmaceuticals (TSE:NRI) Frequently Asked Questions

How has Nuvo Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?

Nuvo Pharmaceuticals' stock was trading at C$0.80 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, NRI stock has increased by 11.3% and is now trading at C$0.89.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Nuvo Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nuvo Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nuvo Pharmaceuticals
.

When is Nuvo Pharmaceuticals' next earnings date?

Nuvo Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for Nuvo Pharmaceuticals
.

How were Nuvo Pharmaceuticals' earnings last quarter?

Nuvo Pharmaceuticals Inc (TSE:NRI) released its earnings results on Monday, August, 10th. The specialty pharmaceutical company reported ($0.17) EPS for the quarter. The specialty pharmaceutical company had revenue of $15.53 million for the quarter, compared to analyst estimates of $14.70 million.
View Nuvo Pharmaceuticals' earnings history
.

Who are some of Nuvo Pharmaceuticals' key competitors?

What other stocks do shareholders of Nuvo Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuvo Pharmaceuticals investors own include Avigilon (AVO), Allena Pharmaceuticals (ALNA), Citius Pharmaceuticals (CTXR), Spartan Energy (SPE), Bombardier, Inc. Class B (BBD.B), Cameco (CCO), Crescent Point Energy (CPG), First Quantum Minerals (FM), Kopin (KOPN) and Leap Therapeutics (LPTX).

Who are Nuvo Pharmaceuticals' key executives?

Nuvo Pharmaceuticals' management team includes the following people:
  • Mr. Robert Paul Harris, Exec. Chairman (Age 64)
  • Mr. Jesse F. Ledger, Pres & CEO
  • Ms. Mary-Jane E. Burkett CPA-CA, HBA, VP & CFO
  • Ms. Katina K. Loucaides M.Sc., LL.B, VP, Corp. Sec. & Gen. Counsel
  • Mr. Calogero Lunetta MSc, VP of Manufacturing

What is Nuvo Pharmaceuticals' stock symbol?

Nuvo Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NRI."

How do I buy shares of Nuvo Pharmaceuticals?

Shares of NRI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Nuvo Pharmaceuticals' stock price today?

One share of NRI stock can currently be purchased for approximately C$0.89.

How big of a company is Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals has a market capitalization of C$10.14 million and generates C$78.31 million in revenue each year. Nuvo Pharmaceuticals employs 97 workers across the globe.

What is Nuvo Pharmaceuticals' official website?

The official website for Nuvo Pharmaceuticals is www.nuvopharmaceuticals.com.

How can I contact Nuvo Pharmaceuticals?

Nuvo Pharmaceuticals' mailing address is 7560 Airport Rd Unit 10, MISSISSAUGA, ON L4T 4H4, Canada. The specialty pharmaceutical company can be reached via phone at +1-905-6736980.

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.